Overview

Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essential to intensify and improve drug delivery approaches.

• What are the widespread methods for drug delivery and how can your team leverage them to achieve growth?
• Which industry-disrupting technologies create potential growth opportunities for your business?
• What are the major growth drivers driving the evolution of this industry?

Quick links

Click here to preview this analysis

Already a member? Click here to access the analysis